{
 "ticker": "BIOY",
 "name": "GraniteShares YieldBOOST Biotech ETF",
 "issuer": "GraniteShares",
 "desk": "income",
 "url": "https://etfiq.com/funds/bioy",
 "html": "https://etfiq.com/funds/bioy",
 "markdown": "https://etfiq.com/funds/bioy.md",
 "as_of": "2026-09-18",
 "verdict": "Since its launch on May 5, 2026, BIOY paid 20.6% in cash and still finished 15.3 points behind XBI.",
 "key_facts": [
  {
   "key": "cash_paid_since_launch_on_its_starting_price",
   "label": "Cash paid, since launch, on its starting price",
   "value": "20.6%",
   "source": null,
   "as_of": "2026-09-18",
   "sentence": "BIOY, cash paid, since launch, on its starting price: 20.6%, as of Sep 18, 2026."
  },
  {
   "key": "total_return_since_launch",
   "label": "Total return, since launch",
   "value": "+2.0%",
   "source": null,
   "as_of": "2026-09-18",
   "sentence": "BIOY, total return, since launch: +2.0%, as of Sep 18, 2026."
  },
  {
   "key": "against_xbi",
   "label": "Against XBI",
   "value": "\u221215.3 pts",
   "source": null,
   "as_of": "2026-09-18",
   "sentence": "BIOY, against XBI: \u221215.3 pts, as of Sep 18, 2026."
  },
  {
   "key": "return_of_capital_latest_payout",
   "label": "Return of capital, latest payout (GraniteShares estimate)",
   "value": "96.3%",
   "source": "GraniteShares estimate",
   "as_of": "2026-09-18",
   "sentence": "BIOY, return of capital, latest payout (GraniteShares estimate): 96.3%, as of Sep 18, 2026."
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$1m",
   "source": "issuer page, as of Sep 18, 2026",
   "as_of": "2026-09-18",
   "sentence": "BIOY, net assets: $1m (issuer page, as of Sep 18, 2026)."
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "1.07%",
   "source": "485BPOS XBRL, Oct 24, 2025",
   "as_of": "2026-09-18",
   "sentence": "BIOY, expense ratio: 1.07% (485BPOS XBRL, Oct 24, 2025)."
  }
 ],
 "fields": [
  {
   "key": "strategy",
   "label": "Strategy",
   "value": "synthetic covered call",
   "source": null
  },
  {
   "key": "benchmark",
   "label": "Benchmark",
   "value": "Biotech (XBI), used as the proxy (proxy)",
   "source": null
  },
  {
   "key": "pays",
   "label": "Pays",
   "value": "weekly",
   "source": null
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$1m",
   "source": "issuer page, as of Sep 18, 2026"
  },
  {
   "key": "latest_payout_annualized",
   "label": "Latest payout, annualized",
   "value": "60.0%",
   "source": "ETFIQ"
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "1.07%",
   "source": "485BPOS XBRL, Oct 24, 2025"
  },
  {
   "key": "cash_paid_last_12_months_over_today_s_price",
   "label": "Cash paid, last 12 months, over today\u2019s price",
   "value": "25.4%",
   "source": "ETFIQ"
  },
  {
   "key": "launched",
   "label": "Launched",
   "value": "May 5, 2026",
   "source": null
  },
  {
   "key": "return_of_capital_latest_distribution",
   "label": "Return of capital, latest distribution",
   "value": "96.3%",
   "source": "GraniteShares 19a-1 estimate"
  }
 ],
 "periods": [
  {
   "window": "3 months",
   "Cash paid": "14.1%",
   "Price": "\u221211.8%",
   "Total return": "+2.5%",
   "XBI": "+11.5%",
   "Ahead or behind": "\u22129.0 pts"
  },
  {
   "window": "Since launch",
   "Cash paid": "20.6%",
   "Price": "\u221219.0%",
   "Total return": "+2.0%",
   "XBI": "+17.3%",
   "Ahead or behind": "\u221215.3 pts"
  }
 ],
 "questions": [
  {
   "q": "How much has BIOY paid over the last year?",
   "a": "Over the period from its launch on May 5, 2026 to Sep 18, 2026, BIOY paid 20.6% of its starting price in cash distributions, while the price fell 19.0%."
  },
  {
   "q": "Is BIOY ahead of XBI?",
   "a": "Over the period from its launch on May 5, 2026 to Sep 18, 2026, with every distribution reinvested, BIOY returned +2.0% against +17.3% for Biotech (XBI), used as the proxy, so a holder was behind it by 15.3 points."
  },
  {
   "q": "How often does BIOY pay, and how much?",
   "a": "BIOY pays weekly. The latest distribution annualizes to 60.0% at its price on Sep 18, 2026, which is not a promise; the next one can differ."
  },
  {
   "q": "Is the BIOY distribution return of capital?",
   "a": "GraniteShares estimates 96% of the distribution paid Aug 25, 2026 was return of capital. That is a tax characterization from the fund's own 19a-1 notice, not a measure of erosion."
  },
  {
   "q": "What does BIOY cost?",
   "a": "The prospectus expense ratio is 1.07% a year."
  }
 ],
 "generated": "2026-09-21",
 "license": "Free to use with attribution. ETFIQ (etfiq.com)."
}